• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.

作者信息

Vierikko P, Kauppila A, Rönnberg L, Vihko R

出版信息

Fertil Steril. 1985 Feb;43(2):218-24.

PMID:2981748
Abstract

Cytosol and nuclear estrogen receptors were detected in 73% and 89% of untreated endometriosis specimens, respectively. The corresponding figures for cytosol and nuclear progestin receptors were 94% and 100%, respectively. Compared with the endometrium, the concentrations in endometriosis tissue were low. The anatomic site, the severity of the disease, and the phase of the menstrual cycle had no significant influence on receptor concentrations in endometriosis tissue. The activities of 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) did not increase during the luteal phase. Danazol for 1, 3, 7 to 11, and 18 to 30 days, or medroxyprogesterone acetate for 5 days, had no effect on receptor concentrations or 17 beta-HSD activity in endometriosis tissue. The frequent presence of the receptors suggests that endometriosis lesions are under the control of steroid hormones. The lack of effect by progesterone and progestins on 17 beta-HSD shows that this regulation is different in endometriosis tissue and in the endometrium.

摘要

相似文献

1
Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.
Fertil Steril. 1985 Feb;43(2):218-24.
2
Cytosol estrogen and progestin receptor concentrations and 17 beta-hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue. Effects of hormonal treatment.子宫内膜和子宫内膜异位组织中的胞质雌激素和孕激素受体浓度以及17β-羟类固醇脱氢酶活性。激素治疗的影响。
Acta Obstet Gynecol Scand Suppl. 1984;123:45-9. doi: 10.3109/00016348409156981.
3
Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17 beta-hydroxysteroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma.
Int J Cancer. 1985 Feb 15;35(2):157-63. doi: 10.1002/ijc.2910350203.
4
Danazol has progestin-like actions on the human endometrium.达那唑对人体子宫内膜有类似孕激素的作用。
Acta Endocrinol (Copenh). 1982 Apr;99(4):588-93. doi: 10.1530/acta.0.0990588.
5
Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17 beta-hydroxysteroid dehydrogenase in human endometrium.他莫昔芬、醋酸甲羟孕酮及其联合用药对人子宫内膜受体动力学和17β-羟类固醇脱氢酶的短期影响。
Obstet Gynecol. 1985 Nov;66(5):695-700.
6
Steroidal drugs in endometriosis.
Acta Obstet Gynecol Scand Suppl. 1989;150:7-13.
7
[Studies on endocrine therapy of endometriosis].[子宫内膜异位症的内分泌治疗研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Aug;41(8):981-9; discussion 1000-7.
8
Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17 beta-hydroxysteroid dehydrogenase activity, and serum hormone concentrations.他莫昔芬、醋酸甲羟孕酮及其联合用药对人子宫内膜雌激素和孕激素受体浓度、17β-羟类固醇脱氢酶活性及血清激素浓度的影响。
Am J Obstet Gynecol. 1982 Jun 15;143(4):382-8. doi: 10.1016/0002-9378(82)90077-1.
9
Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.雌激素和孕激素受体浓度对子宫内膜癌临床结局的预测及其与临床和组织病理学变量的关系
Cancer Res. 1986 Oct;46(10):5380-4.
10
Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
Fertil Steril. 1989 Jul;52(1):31-5. doi: 10.1016/s0015-0282(16)60784-7.

引用本文的文献

1
Single-cell and spatial transcriptomic profiling revealed niche interactions sustaining growth of endometriotic lesions.单细胞和空间转录组分析揭示了维持子宫内膜异位症病灶生长的微环境相互作用。
Cell Genom. 2025 Jan 8;5(1):100737. doi: 10.1016/j.xgen.2024.100737.
2
Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives.子宫内膜异位症中的孕激素抵抗:病理生理学视角及潜在的治疗选择
Reprod Med Biol. 2024 Jun 7;23(1):e12588. doi: 10.1002/rmb2.12588. eCollection 2024 Jan-Dec.
3
Phytoprogestins: Unexplored Food Compounds with Potential Preventive and Therapeutic Effects in Female Diseases.
植物性孕激素:具有预防和治疗女性疾病潜力的未开发食物化合物。
Nutrients. 2021 Nov 30;13(12):4326. doi: 10.3390/nu13124326.
4
Adenomyosis pathogenesis: insights from next-generation sequencing.子宫腺肌病发病机制的研究进展:下一代测序技术的启示。
Hum Reprod Update. 2021 Oct 18;27(6):1086-1097. doi: 10.1093/humupd/dmab017.
5
The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.柚皮苷(Naringenin)作为黄酮类化合物,可调节来曲唑诱导的多囊卵巢综合征大鼠模型的抗氧化和甾体生成酶活性。
Med Sci Monit. 2019 Jan 13;25:395-401. doi: 10.12659/MSM.912341.
6
Medical treatments for endometriosis-associated pelvic pain.子宫内膜异位症相关盆腔疼痛的医学治疗方法。
Biomed Res Int. 2014;2014:191967. doi: 10.1155/2014/191967. Epub 2014 Aug 7.
7
Biological characterization of non-steroidal progestins from botanicals used for women's health.植物源非甾体孕激素的生物学特性及其在女性健康中的应用。
Steroids. 2012 Jun;77(7):765-73. doi: 10.1016/j.steroids.2012.03.013. Epub 2012 Apr 5.
8
17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis.内异症中 17β-羟类固醇脱氢酶-2 缺乏和孕酮抵抗。
Semin Reprod Med. 2010 Jan;28(1):44-50. doi: 10.1055/s-0029-1242992.
9
Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis.患有与未患有子宫内膜异位症的女性子宫内膜基质细胞中类固醇生成酶和关键蜕膜化标志物的失调
Biol Reprod. 2009 Jan;80(1):105-14. doi: 10.1095/biolreprod.108.070300. Epub 2008 Sep 24.
10
Pseudo-decidualization at the site of implantation in tubal pregnancy.输卵管妊娠着床部位的假蜕膜样变。
Arch Gynecol Obstet. 1993;253(2):85-95. doi: 10.1007/BF02768734.